Moreover, accumulated evidence has demonstrated that Cox-2 inhibitors are able to sensitize cancer cells to the anti-proliferative effects of chemotherapeutic drugs by altering the activity of the ATP-binding cassette protein. This evidence concerns the gene PTGS2 and cancer.